15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043.
University of Notre Dame
Discovery of novel pyrimidinetrione derivatives as DprE1 inhibitors with potent antimycobacterial activities.
Shenyang Pharmaceutical University
Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinones.
Leibniz-HKI
Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis.
Zhejiang University
Benzothiozinone derivatives with anti-tubercular Activity-Further side chain investigation.
Suzhou Medical College of Soochow University
Targeting mycobacterial membranes and membrane proteins: Progress and limitations.
National Institute of Pharmaceutical Education and Research-Hyderabad
Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.
Peking Union Medical College and Chinese Academy of Medical Sciences
Exploring disordered loops in DprE1 provides a functional site to combat drug-resistance in Mycobacterium strains.
Northwest A&F University
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents.
Soochow University
Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities.
Peking Union Medical College and Chinese Academy of Medical Sciences
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents.
Soochow University
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Soochow University
Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors.
University of Antwerp